Ranitidine Hydrochloride · RANITIDINE HYDROCHLORIDE 300 mg/1 · Capsule · Oral · Dr. Reddy's Laboratories Limited
NDC 55111-0130-30 · 30 CAPSULE in 1 BOTTLE · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has fallen 45% in a year, to $0.5821 per unit — and generics that get this cheap tend to get abandoned rather than defended.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Dr. Reddy's Laboratories Limited | RANITIDINE HYDROCHLORIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Limited | RANITIDINE HYDROCHLORIDE 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Ranitidine Hydrochloride — NDC 55111-0130-30," retrieved September 3, 2026, https://drugdashboards.com/drug/55111013030.
Free to cite with attribution — see how the data is put together.